Overview
- Judge Ernesto Kreplak forwarded 159 cases — 111 fatalities and 48 survivors — to forensic experts for case‑by‑case analysis that could refine the final toll.
- Lab and forensic reports detected multiresistant bacteria, including Klebsiella and Ralstonia species, in sealed ampoules that increased patients’ risk of death.
- Investigators traced the outbreak to production lot 31202, with batch records showing consecutive manufacturing without proper cleaning in December 2024.
- The drug was manufactured and distributed by Ramallo S.A. and HLB Pharma; owner Ariel García Furfaro is processed and in preventive detention, with further questioning planned.
- Congress is expected to take up oversight and medicine‑traceability reforms in March following recommendations from a special investigative commission.